Diagnosis and treatment of systemic mastocytosis: State of the art

被引：160
作者：
Valent, P
Akin, C
Sperr, WR
Horny, HP
Arock, M
Lechner, K
Bennett, JM
Metcalfe, DD
机构：
[1] Univ Vienna, Dept Internal Med 1, Div Haematol, A-1010 Vienna, Austria
[2] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA
[3] Med Univ Lubeck, Inst Pathol, Lubeck, Germany
[4] Fac Pharm, Lab Hematol Cellulaire & Mol, Paris, France
[5] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Med Oncol Div, Rochester, NY 14642 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2003年 / 122卷 / 05期
关键词：
D O I：
10.1046/j.1365-2141.2003.04575.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：695 / 717
页数：23
相关论文
共 173 条
[1]   Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes [J].
Agis, H ;
Fureder, W ;
Bankl, HC ;
Kundi, M ;
Sperr, WR ;
Willheim, M ;
BoltzNitulescu, G ;
Butterfield, JH ;
Kishi, K ;
Lechner, K ;
Valent, P .
IMMUNOLOGY, 1996, 87 (04) :535-543
[2]  
AGIS H, 1993, J IMMUNOL, V151, P4221
[3]   Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis [J].
Akin, C ;
Kirshenbaum, AS ;
Semere, T ;
Worobec, AS ;
Scott, LM ;
Metcalfe, DD .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) :140-147
[4]   Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology [J].
Akin, C ;
Schwartz, LB ;
Kitoh, T ;
Obayashi, H ;
Worobec, AS ;
Scott, LM ;
Metcalfe, DD .
BLOOD, 2000, 96 (04) :1267-1273
[5]   Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit [J].
Akin, C ;
Brockow, K ;
D'Ambrosio, C ;
Kirshenbaum, AS ;
Ma, YS ;
Longley, BJ ;
Metcalfe, DD .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (08) :686-692
[6]   Surrogate markers of disease in mastocytosis [J].
Akin, C ;
Metcalfe, DD .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 127 (02) :133-136
[7]   Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case? [J].
Akin, C ;
Scott, LM ;
Metcalfe, DD .
LEUKEMIA RESEARCH, 2001, 25 (07) :635-638
[8]   DISODIUM-CROMOGLYCATE IN THE TREATMENT OF SYSTEMIC MASTOCYTOSIS INVOLVING ONLY BONE [J].
ALEXANDER, RR .
ACTA HAEMATOLOGICA, 1985, 74 (02) :108-110
[9]   SYSTEMIC MASTOCYTOSIS [J].
AUSTEN, KF .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :639-640
[10]   Bone marrow angiogenesis in systemic mast cell disease [J].
Baek, JY ;
Li, CY ;
Pardanani, A ;
Butterfield, JH ;
Tefferi, A .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (01) :139-146
12345678910